REGEN COVERED FOR REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)

Business administration services, namely, business administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Business administration services, namely, business administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Financial administration services, namely, financial administration of a program to provide access to pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders at low or no cost to underserved populations; Financial administration services, namely, financial administration of a program to provide discounts on prescription pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Medical and pharmaceutical consultation regarding pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders